SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-216525
Filing Date
2011-08-09
Accepted
2011-08-09 16:19:10
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 583096
2 AMENDMENT NO. 1 TO COLLABORATION AGREEMENT dex101.htm EX-10.1 12180
3 AMENDMENT NO. 2 TO COLLABORATION AGREEMENT dex102.htm EX-10.2 28421
4 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) dex311.htm EX-31.1 6078
5 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) dex312.htm EX-31.2 6102
6 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 4461
  Complete submission text file 0001193125-11-216525.txt   1864736

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mdvn-20110630.xml EX-101.INS 216814
8 XBRL TAXONOMY EXTENSION SCHEMA mdvn-20110630.xsd EX-101.SCH 14690
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdvn-20110630_cal.xml EX-101.CAL 29457
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdvn-20110630_lab.xml EX-101.LAB 100199
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdvn-20110630_pre.xml EX-101.PRE 66106
Mailing Address 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO CA 94105
Business Address 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO CA 94105 415-543-3470
MEDIVATION, INC. (Filer) CIK: 0001011835 (see all company filings)

IRS No.: 133863260 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32836 | Film No.: 111021029
SIC: 2834 Pharmaceutical Preparations